Ovid seeks metamorphosis into public company with $86M IPO

This follows on from a fairly quiet start to the year in terms of public offerings from biotech, although just this week Biohaven Pharmaceutical filed to raise up to $100 million in its IPO attempt to … Ovid help out on the Osaka-based company’s …
( read original story …)


Related Post

American in Japan describes jolting North Korean m...
views 162
North Korea's official KCNA news agency reported t...
Fukushima may have been leaking radioactive water,...
views 181
The Asahi Shimbun reported Tokyo Electric Power co...
DIARY-Top Economic Events to June 23
views 264
TUESDAY, MAY 2 ** BERLIN - German Finance Minister...
X Japan's Yoshiki needs urgent surgery after ...
views 232
The frenetic, intense drumming style of one of Jap...
Japan, India to ink controversial nuclear deal
views 226
Japan and India are set to sign a controversial ci...
RPT-Japanese private equity emerging from its torp...
views 227
GOOD YEAR TO RAISE FUNDS As Japan's central bank i...
ICHHTO to Attend Tokyo Gift Show
views 198
Iranian artisans will participate in the Tokyo Int...
Japan October factory output steady, November seen...
views 196
TOKYO (Reuters) - Japan's industrial output rose i...
Tokyo shares rebound as trade war fears ease
views 137
Tokyo stocks ended higher on Thursday ... In trade...
Japan’s 100-year-old Prince Mikasa passes away
views 229
He breathed his last at 8.34 a.m. on Thursday at S...